Bio Pharma Dive
OCTOBER 20, 2023
With the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential for antibody-drug conjugates to reshape cancer treatment.
Pharmaceutical Technology
OCTOBER 20, 2023
NVIDIA’s vice-president of healthcare, Kimberly Powell, discussed GenAI in pharma and the importance of partnerships.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
OCTOBER 20, 2023
The deal is worth up to $22 billion in total, making it one of the largest pharmaceutical licensing agreements by value.
Pharmaceutical Technology
OCTOBER 20, 2023
Health Canada has granted a Notice of Compliance (NOC) to Sumitomo Pharma Canada and Pfizer Canada’s MYFEMBREE.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Times
OCTOBER 20, 2023
Global innovators can apply to PACE to receive up to £1m per project - News - PharmaTimes
Pharmaceutical Technology
OCTOBER 20, 2023
The company plans to initiate the Phase II trial of anti-IL-6 antibody in atherosclerotic cardiovascular disease in 2024.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
OCTOBER 20, 2023
Meilleur’s [F-18]NAV-4694 will be used as a biomarker in ADNI4’s Alzheimer’s disease research.
Antidote
OCTOBER 20, 2023
Since 1999, October has been designated as Health Literacy Month , a month dedicated to promoting patient-centricity in healthcare communications across the industry. Health literacy refers to a person’s ability to find, understand, and use health-related services and make informed decisions for themselves and others.
Pharmaceutical Technology
OCTOBER 20, 2023
Daiichi Sankyo will receive an upfront payment of $4bn and will be eligible for additional milestone payments of up to $22bn.
pharmaphorum
OCTOBER 20, 2023
How quality of life can drive equitable cancer care and outcomes Mike.
Pharmaceutical Technology
OCTOBER 20, 2023
UCB’s drug is the first IL-17A and IL-17F inhibitor approved for patients with moderate to severe plaque psoriasis.
pharmaphorum
OCTOBER 20, 2023
At CAR-TCR last month in Boston, pharmaphorum Editor in Chief Jonah Comstock grabbed some time with Tim McGuire, director of business development at biomanufacturer Resilience.
Pharmaceutical Technology
OCTOBER 20, 2023
The company has said that it is ready to launch a Phase IIa trial with the drug being intended to treat an often painful condition.
Fierce Pharma
OCTOBER 20, 2023
Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers. | Eli Lilly is on a roll with its RET inhibitor Retevmo, with new trial results showing the drug can offer dramatic benefits in the treatment of certain lung and thyroid cancers.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
OCTOBER 20, 2023
Over 20,000 people and businesses in the UK have already been approached by Chinese spies, warned MI5 head Ken McCallum.
pharmaphorum
OCTOBER 20, 2023
EU clears path for Pfizer’s takeover of Seagen Phil.
Pharmaceutical Technology
OCTOBER 20, 2023
AI is going to transform every single job and it’s already begun to happen, said Filippo Bonsanti, VP of global marketing at Indeed.
Outsourcing Pharma
OCTOBER 20, 2023
A small molecule kinase inhibitor has been trialed in humans for the first time as part of a glioblastoma treatment study.
Pharmaceutical Technology
OCTOBER 20, 2023
The European Commission (EC) has granted unconditional approval to Pfizer for the prospective takeover of Seagen for $43bn in cash.
pharmaphorum
OCTOBER 20, 2023
Amwell, Leidos win $180m US military digital health contract Phil.
Pharmaceutical Technology
OCTOBER 20, 2023
Roche has posted a 7% rise in group sales to SFr14.27bn ($15.91bn) at constant exchange rates (CER) in Q3 2023.
Intouch Solutions
OCTOBER 20, 2023
This year’s Dreamforce conference – the annual gathering for Salesforce, one of the main providers in commercial marketing and sales technology for the Health & Life Science (HLS) industry – was bigger and more innovative than ever. But what news will matter most for health & life sciences companies? An EVERSANA INTOUCH team attends each year to get the latest on the technologies coming to market and to get inspired on the best ways to use them for our clients.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Technology
OCTOBER 20, 2023
Endeavor BioMedicines has acquired exclusive global rights to the HER3-targeted antibody-drug conjugate (ADC) of Hummingbird Bio, HMBD-501.
Fierce Pharma
OCTOBER 20, 2023
In the race to secure U.S. approval for the first five-pronged meningitis vaccine, Pfizer has eked out a regulatory win well ahead of its immunization rival GSK. | The U.S. FDA gave a thumbs-up to Penbraya, the commercial moniker for Pfizer’s pentavalent vaccine defending against the most common serogroups behind meningococcal disease. The shot is approved for adolescents and adults between the ages of 10 and 25.
pharmaphorum
OCTOBER 20, 2023
Young hit hardest by England’s ‘community health crisis’ Phil.
Drug Patent Watch
OCTOBER 20, 2023
This chart shows the drugs with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Canada? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
OCTOBER 20, 2023
MSD sinks $4bn upfront into ADC pact with Daiichi Sankyo Phil.
Fierce Pharma
OCTOBER 20, 2023
At ESMO, Merck is encouraged by Welireg's potential to treat clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer.
Pharmaceutical Commerce
OCTOBER 20, 2023
Partnership intends to indirectly boost patient medication adherence rates in the process.
Rethinking Clinical Trials
OCTOBER 20, 2023
How Do You Design Trials That Are Fit for Purpose? Description Dr. Lesley Curtis discusses how to design trials that are fit for purpose. Speaker Lesley Curtis, PhD Professor of Population Health Sciences and Medicine, Duke University Duke Clinical Research Institute Collaboratory Steering Committee Chair The post How Do You Design Trials That Are Fit for Purpose?
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
278 
Let's personalize your content